Actively Recruiting
GLOW Study: Effects of Triple Protein in Women
Led by University of North Carolina, Chapel Hill · Updated on 2026-04-13
40
Participants Needed
1
Research Sites
34 weeks
Total Duration
On this page
Sponsors
U
University of North Carolina, Chapel Hill
Lead Sponsor
P
Perelel Inc.
Collaborating Sponsor
AI-Summary
What this Trial Is About
This single-site, randomized, blinded, placebo-controlled study will evaluate whether 4 weeks of daily Triple Support Protein powder improves glycemic control and overall well-being in healthy women aged 30-60 years. Participants will undergo baseline testing (DXA, fasting blood, standardized meal test with 2-hour glucose and insulin sampling), complete one acute supervised dose, and then consume a daily supplement for 4 weeks. During the final 14 days, participants will wear a continuous glucose monitor. Outcomes include postprandial glucose AUC, insulin sensitivity, and body composition.
CONDITIONS
Official Title
GLOW Study: Effects of Triple Protein in Women
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female aged 30 to 60 years
- Body mass index (BMI) between 18.5 and 40 kg/m2
- Recreationally active with at least 30 minutes of moderate intensity exercise per week
- Healthy and free from disease based on health history questionnaire
- Willing to avoid caffeine, tobacco, and alcohol for 24 hours before testing days
You will not qualify if you...
- Currently taking whey protein supplements
- Pregnant or nursing
- Lactose intolerant
- Currently using creatine monohydrate
- Severe hearing or speech impairment or unable to speak English
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Exercise and Sport Science, Applied Physiology Laboratory
Chapel Hill, North Carolina, United States, 27713
Actively Recruiting
Research Team
A
Abbie Smith-Ryan
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here